These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

829 related articles for article (PubMed ID: 32673595)

  • 1. Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis.
    Zhou G; Luo Q; Luo S; Teng Z; Ji Z; Yang J; Wang F; Wen S; Ding Z; Li L; Chen T; Abi ME; Jian M; Luo L; Liu A; Bao F
    Lancet Infect Dis; 2020 Dec; 20(12):1457-1469. PubMed ID: 32673595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis.
    Auguste P; Tsertsvadze A; Pink J; Court R; McCarthy N; Sutcliffe P; Clarke A
    BMC Infect Dis; 2017 Mar; 17(1):200. PubMed ID: 28274215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis.
    Krutikov M; Faust L; Nikolayevskyy V; Hamada Y; Gupta RK; Cirillo D; Mateelli A; Korobitsyn A; Denkinger CM; Rangaka MX
    Lancet Infect Dis; 2022 Feb; 22(2):250-264. PubMed ID: 34606768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.
    Gran G; Aßmus J; Dyrhol-Riise AM
    BMC Public Health; 2013 Apr; 13():353. PubMed ID: 23590619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis.
    Diel R; Loddenkemper R; Nienhaus A
    Chest; 2012 Jul; 142(1):63-75. PubMed ID: 22490872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study.
    Ho CS; Feng PI; Narita M; Stout JE; Chen M; Pascopella L; Garfein R; Reves R; Katz DJ;
    Lancet Infect Dis; 2022 Jan; 22(1):85-96. PubMed ID: 34499863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study.
    Gao L; Li X; Liu J; Wang X; Lu W; Bai L; Xin H; Zhang H; Li H; Zhang Z; Ma Y; Li M; Feng B; Du J; Sui H; Zhao R; Su H; Pan S; Guan L; Shen F; He J; Yang S; Si H; Cheng X; Xu Z; Tan Y; Chen T; Xu W; Peng H; Wang Z; Zhu T; Chen X; Zhou X; Guan X; Jin Q;
    Lancet Infect Dis; 2017 Oct; 17(10):1053-1061. PubMed ID: 28716677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Kahwati LC; Feltner C; Halpern M; Woodell CL; Boland E; Amick HR; Weber RP; Jonas DE
    JAMA; 2016 Sep; 316(9):970-83. PubMed ID: 27599332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of progression to active tuberculosis for indeterminate interferon-gamma release assay in immunocompromised individuals: a systematic review and meta-analysis.
    Zhou G; Luo S; He J; Chen N; Zhang Y; Cai S; Guo X; Song C
    Clin Microbiol Infect; 2023 Nov; 29(11):1375-1384. PubMed ID: 37422080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study.
    Abubakar I; Drobniewski F; Southern J; Sitch AJ; Jackson C; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Lynn W; Burgess H; Mann B; Imran A; Sridhar S; Tsou CY; Nikolayevskyy V; Rees-Roberts M; Whitworth H; Kon OM; Haldar P; Kunst H; Anderson S; Hayward A; Watson JM; Milburn H; Lalvani A;
    Lancet Infect Dis; 2018 Oct; 18(10):1077-1087. PubMed ID: 30174209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
    Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES
    PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.
    Blount RJ; Tran MC; Everett CK; Cattamanchi A; Metcalfe JZ; Connor D; Miller CR; Grinsdale J; Higashi J; Nahid P
    BMC Public Health; 2016 Aug; 16(1):875. PubMed ID: 27558397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
    Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis.
    Campbell JR; Winters N; Menzies D
    BMJ; 2020 Mar; 368():m549. PubMed ID: 32156698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis.
    Diel R; Goletti D; Ferrara G; Bothamley G; Cirillo D; Kampmann B; Lange C; Losi M; Markova R; Migliori GB; Nienhaus A; Ruhwald M; Wagner D; Zellweger JP; Huitric E; Sandgren A; Manissero D
    Eur Respir J; 2011 Jan; 37(1):88-99. PubMed ID: 21030451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent tuberculosis infection in transplant candidates: a systematic review and meta-analysis on TST and IGRA.
    Nasiri MJ; Pormohammad A; Goudarzi H; Mardani M; Zamani S; Migliori GB; Sotgiu G
    Infection; 2019 Jun; 47(3):353-361. PubMed ID: 30805899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.